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Abstract
Background: The World Health Organization (WHO), like many other organisations around the
world, has recognised the need to use more rigorous processes to ensure that health care
recommendations are informed by the best available research evidence. This is the 15th of a series
of 16 reviews that have been prepared as background for advice from the WHO Advisory
Committee on Health Research to WHO on how to achieve this.
Objectives: In this review we address strategies for the implementation of recommendations in
health care.
Methods: We examined overviews of systematic reviews of interventions to improve health care
delivery and health care systems prepared by the Cochrane Effective Practice and Organisation of
Care (EPOC) group. We also conducted searches using PubMed and three databases of
methodological studies for existing systematic reviews and relevant methodological research. We
did not conduct systematic reviews ourselves. Our conclusions are based on the available evidence,
consideration of what WHO and other organisations are doing and logical arguments.
Key questions and answers: What should WHO do to disseminate and facilitate the
uptake of recommendations?
• WHO should choose strategies to implement their guidelines from among those which have been
evaluated positively in the published literature on implementation research
• Because the evidence base is weak and modest to moderate effects, at best, can be anticipated,
WHO should promote rigorous evaluations of implementation strategies.
What should be done at headquarters, by regional offices and in countries?
• Adaptation and implementation of WHO guidelines should be done locally, at the national or sub-
national level.
• WHO headquarters and regional offices should support the development and evaluation of 
implementation strategies by local authorities.
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Background
The World Health Organization (WHO), like many other
organisations around the world, has recognised the need
to use more rigorous processes to ensure that health care
recommendations are informed by the best available
research evidence. This is the 15th of a series of 16 reviews
that have been prepared as background for advice from
the WHO Advisory Committee on Health Research to
WHO on how to achieve this.
Developing recommendations makes little sense if they
are not used. Thus, effective strategies to promote the
appropriate use of recommendations by decision-makers
(clinicians, public health officers, policymakers) are
important.
In this paper we address the following questions:
￿ What should WHO do to disseminate and facilitate the
uptake of recommendations?
￿ What should be done at headquarters, by regional
offices and in countries?
Questions related to adaptation and evaluation of guide-
lines are addressed in other papers in this series [1,2].
What is WHO doing now?
There is no general WHO strategy for guideline imple-
mentation. The methods that are used vary from depart-
ment to department, and may vary from case to case
within departments. Field testing and rollout strategies
that are used to promote the uptake of recommendations
are often not informed by the findings of implementation
research, and it is generally difficult to estimate the impact
of the implementation strategies that are used, since eval-
uations are rarely rigorous, if they are done at all.
There are, however, examples of rigorous evaluations,
such as implementation of the Integrated Management
for Childhood Illnesses (IMCI) guideline, which has been
evaluated in a randomised controlled trial [3]. WHO has
also in some cases reviewed the relevant evidence-base,
for example for strategies to improve the use of drugs in
developing countries [4].
Although recommendations inevitably need to be
adapted and implemented at country level, WHO head-
quarters and regional offices can support these activities
[2].
What are other organisations doing?
In an international survey of organisations that develop
guidelines or health technology assessments, almost half
of the 95 respondents reported using provider-mediated
interventions as part of their strategy for implementing of
guidelines [5]. Examples of this were conducting audits
and hosting work-shops for practitioners. However, many
respondents did not provide specific examples.
In a smaller international survey of prominent guideline
developers, nearly all of the 18 organisations used educa-
tional materials and conferences as part of their imple-
mentation strategies [6]. Other common approaches were
audit and feed-back, use of local opinion leaders, and
organizational interventions (e.g. financial incentives or
disincentives).
Methods
The methods used to prepare this review are described in
the introduction to this series [7]. The key questions
addressed in this paper were vetted amongst the authors
and the ACHR Subcommittee on the Use of Research Evi-
dence (SURE). The Cochrane Effective Practice and
Organisation of Care (EPOC) group undertakes system-
atic reviews of interventions to improve health care deliv-
ery and health care systems. EPOC has undertaken
periodic overviews of systematic reviews to assess and
summarise the evidence available from existing Cochrane
and non Cochrane reviews [8-10]. The research findings
reported here are drawn from these overviews and an
update of those overviews that is underway. In addition,
we searched PubMed and three databases of methodolog-
ical literature (within the databases of The Cochrane
Library, the US National Guideline Clearinghouse [11]
and the Guidelines International Network [12]) for exist-
ing systematic reviews and relevant methodological
research that address these questions. The search-term we
used was "guidelines and implementation and systematic
review".
We did not conduct systematic reviews ourselves. The
answers to the questions are our conclusions based on the
available evidence, consideration of what WHO and other
organisations are doing and logical arguments.
Findings
What should WHO do to disseminate and facilitate the 
uptake of recommendations?
Most research on implementation and dissemination
strategies for guidelines have focused on clinical practice
guidelines, with change in clinical practice being the pri-
mary outcome of interest. An overview of systematic
reviews of interventions aimed at changing provider
behaviour found that: "In general, passive approaches are
generally ineffective and unlikely to result in behaviour
change. Most other interventions are effective under some
circumstances; none are effective under all circumstances.
Promising approaches include educational outreach (for
prescribing) and reminders" [9]. A more recent compre-Health Research Policy and Systems 2006, 4:27 http://www.health-policy-systems.com/content/4/1/27
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hensive review of evaluations of the effects of strategies for
guideline implementation found that "The majority of
interventions observed modest to moderate improve-
ments in care", but there was "considerable variation in
the observed effects both within and across interven-
tions"[13].
Few evaluations of interventions to change professional
practice have been conducted in low-income countries
[14].
Guidance from WHO is often directed towards policy-
makers. There is limited research to inform the choice of
strategies to improve the uptake of WHO recommenda-
tions by policymakers. The findings of systematic reviews
of studies of decision-making by health care managers
and policymakers have found that factors such as interac-
tions between researchers and health care policy-makers
and timing/timeliness appear to increase the prospects for
research use among policymakers [15,16].
What should be done at headquarters, by regional offices 
and in countries?
We did not identify any research findings that could
inform the answer to this question.
Discussion
Passive dissemination of guidelines alone is not likely to
adequately ensure appropriate uptake of recommenda-
tions in most circumstances. However, the conclusion in
an extensive review of guidelines implementation strate-
gies was: "There is an imperfect evidence base to support
decisions about which guideline dissemination and
implementation strategies are likely to be efficient under
different circumstances" [13]. Thus, WHO needs to care-
fully consider the likely benefits and costs of alternative
implementation strategies in relationship to specific con-
texts, and to evaluate the impact of selected strategies.
There are tools available that are designed to assist in the
design and evaluation of implementation strategies, such
as NorthStar, developed by the EC-funded Research-based
continuing education and quality improvement (ReBEQI)
project [17]. NorthStar provides a range of information,
checklists, examples and tools based on current research
on how to best design and evaluate implementation strat-
egies.
Health authorities at national or sub-national levels are
better able than WHO to tailor implementation strategies
to their specific circumstances. However, they frequently
lack capacity and resources to do this. WHO headquarters
and regional offices can play an important role in support-
ing member states in their efforts to implement recom-
mendations by providing tools such as NorthStar, support
and coordination of efforts.
Further work
Rigorous evaluations of the effectiveness of strategies for
implementing and disseminating recommendations are
needed. Given that the use and impact of WHO recom-
mendations is likely to be limited without an active
implementation strategy, it is of paramount interest to the
organisation to invest in generating the knowledge
needed for successful implementation.
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